These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30522911)

  • 1. Transjugular intrahepatic portosystemic shunt (TIPS) placement: A comparison of outcomes between patients with hepatic hydrothorax and patients with refractory ascites.
    Young S; Bermudez J; Zhang L; Rostambeigi N; Golzarian J
    Diagn Interv Imaging; 2019 May; 100(5):303-308. PubMed ID: 30522911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.
    Gordon FD; Anastopoulos HT; Crenshaw W; Gilchrist B; McEniff N; Falchuk KR; LoCicero J; Lewis WD; Jenkins RL; Trey C
    Hepatology; 1997 Jun; 25(6):1366-9. PubMed ID: 9185754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.
    Campos S; Gomes D; Sofia C
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):661-6. PubMed ID: 27002676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients.
    Siegerstetter V; Deibert P; Ochs A; Olschewski M; Blum HE; Rössle M
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):529-34. PubMed ID: 11396532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.
    Jeffries MA; Kazanjian S; Wilson M; Punch J; Fontana RJ
    Liver Transpl Surg; 1998 Sep; 4(5):416-23. PubMed ID: 9724480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experience with covered transjugular intrahepatic portosystemic shunt for refractory ascites from western India.
    Amarapurkar DN; Punamiya S; Patel ND
    Ann Hepatol; 2006; 5(2):103-8. PubMed ID: 16807516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
    Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
    Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
    Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
    Am J Gastroenterol; 2010 Mar; 105(3):635-41. PubMed ID: 19904245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
    Tan HK; James PD; Sniderman KW; Wong F
    J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients.
    Gou X; Jia W; He C; Yuan X; Niu J; Xu J; Han N; Zhu Y; Wang W; Tie J
    Eur Radiol; 2023 May; 33(5):3407-3415. PubMed ID: 36576548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of refractory hepatic hydrothorax that was not treated by transjugular intrahepatic portosystemic shunt].
    Park HW; Huh W; Kim SJ; Shin WC; Choi WC; Lee JH
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):327-30. PubMed ID: 12499792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt: current status.
    Boyer TD
    Gastroenterology; 2003 May; 124(6):1700-10. PubMed ID: 12761727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of refractory hepatic hydrothorax.
    Porcel JM
    Curr Opin Pulm Med; 2014 Jul; 20(4):352-7. PubMed ID: 24811830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary creation of an externally constrained TIPS: a technique to control reduction of the portosystemic gradient.
    Farsad K; Kolbeck KJ; Keller FS; Barton RE; Kaufman JA
    AJR Am J Roentgenol; 2015 Apr; 204(4):868-71. PubMed ID: 25794080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.
    Maleux G; Nevens F; Wilmer A; Heye S; Verslype C; Thijs M; Wilms G
    Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.
    Wallace MJ; Madoff DC; Ahrar K; Warneke CL
    Cancer; 2004 Jul; 101(2):337-45. PubMed ID: 15241832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax.
    LaBerge JM
    Clin Liver Dis; 2006 Aug; 10(3):583-98, ix. PubMed ID: 17162229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients.
    Wilputte JY; Goffette P; Zech F; Godoy-Gepert A; Geubel A
    Acta Gastroenterol Belg; 2007; 70(1):6-10. PubMed ID: 17619531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax.
    Spencer EB; Cohen DT; Darcy MD
    J Vasc Interv Radiol; 2002 Apr; 13(4):385-90. PubMed ID: 11932369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt.
    Degawa M; Hamasaki K; Yano K; Nakao K; Kato Y; Sakamoto I; Nakata K; Eguchi K
    J Gastroenterol; 1999 Feb; 34(1):128-31. PubMed ID: 10204623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.